Eli Lilly and Company

lilly.com · Indianapolis, United States of America

Eli Lilly and Company is a global pharmaceutical manufacturer that discovers, develops, and commercializes prescription medicines across areas such as diabetes, oncology, immunology, neuroscience, and obesity. It sells its drugs to healthcare providers, hospitals, pharmacies, and governments worldwide through branded and, in some cases, partnered distribution channels. The company generates revenue primarily from patented therapeutics and related pharmaceutical products and collaborations.

Revenue
$34.5B
Employees
43,000
Founded
1876
Headquarters
Indianapolis, United States of America

What 9 Arbolus experts think of Eli Lilly and Company

NPS scores are highly positive, with 67% at 9 or above and no observed detractor scores. Renewal intent is mixed, as two Influencers indicate uncertainty despite high spend. Stickiness is strong, with 56% of responses indicating usage beyond one year and pilot activity indicating new expansion. Key themes are sustained user satisfaction and strong adoption at the operational level.Overall Customer Sentiment: Positive

Who reviewed Eli Lilly and Company

Total customers 9 9 current · 0 former
Reviews growth +7 in six months
Seniority of respondents
  • C-Suite 67% (6)
  • Director 22% (2)
  • Manager 11% (1)
Operations Ops C-Suite NPS 10 Undecided
Strategy Partner C-Suite NPS 9
Revenue Leader C-Suite NPS 10

Employer names and spend open once the report publishes.

Tell us when the Eli Lilly and Company report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

55 Net Promoter Score, from 9 scored reviews
  • Promoters 6
  • Passives 2
  • Detractors 1

Cumulative NPS by month

+1 over 6 months
  • Feb 8
  • May 9
  • Jun 8
  • Jul 8
  • Aug 8
  • Sep 9

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 55 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 33%
  • Will renew 1
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 50% 2 answers
  • Manager 0% 1 answer
  • 8/10 Average score from customers who will renew
  • 8.5/10 Average score from undecided customers

For people who use Eli Lilly and Company

Do you use Eli Lilly and Company at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 9 customers of Eli Lilly and Company have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.